Aripiprazole

An appraisal of the translation of complex receptor effects into clinical outcomes

Peter F. Buckley, C Simon Sebastian

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

Aripiprazole possesses a complex pharmacology with both partial agonist and full antagonist effects. The purpose of this article is to critically review, in the light of its unique receptor pharmacology, the current clinical literature on the use of aripiprazole in the treatment of schizophrenia and mood disorders. There is evidence that aripiprazole is an effective and well tolerated antipsychotic in treating schizophrenia. Now, more recent evidence suggests that aripiprazole may have a role in the treatment of mood disorders. The efficacy side-effect profile of aripiprazole is reviewed herein.

Original languageEnglish (US)
Pages (from-to)699-707
Number of pages9
JournalTherapy
Volume2
Issue number5
DOIs
StatePublished - Sep 1 2005

Fingerprint

Mood Disorders
Schizophrenia
Clinical Pharmacology
Antipsychotic Agents
Aripiprazole
Pharmacology

Keywords

  • Aripiprazole
  • Mood disorders
  • Schizophrenia

ASJC Scopus subject areas

  • Pharmacology (medical)

Cite this

Aripiprazole : An appraisal of the translation of complex receptor effects into clinical outcomes. / Buckley, Peter F.; Sebastian, C Simon.

In: Therapy, Vol. 2, No. 5, 01.09.2005, p. 699-707.

Research output: Contribution to journalReview article

@article{83d1676da2f24e01b81829226208ac6c,
title = "Aripiprazole: An appraisal of the translation of complex receptor effects into clinical outcomes",
abstract = "Aripiprazole possesses a complex pharmacology with both partial agonist and full antagonist effects. The purpose of this article is to critically review, in the light of its unique receptor pharmacology, the current clinical literature on the use of aripiprazole in the treatment of schizophrenia and mood disorders. There is evidence that aripiprazole is an effective and well tolerated antipsychotic in treating schizophrenia. Now, more recent evidence suggests that aripiprazole may have a role in the treatment of mood disorders. The efficacy side-effect profile of aripiprazole is reviewed herein.",
keywords = "Aripiprazole, Mood disorders, Schizophrenia",
author = "Buckley, {Peter F.} and Sebastian, {C Simon}",
year = "2005",
month = "9",
day = "1",
doi = "10.1586/14750708.2.5.699",
language = "English (US)",
volume = "2",
pages = "699--707",
journal = "Therapy",
issn = "2044-9038",
publisher = "Future Medicine Ltd.",
number = "5",

}

TY - JOUR

T1 - Aripiprazole

T2 - An appraisal of the translation of complex receptor effects into clinical outcomes

AU - Buckley, Peter F.

AU - Sebastian, C Simon

PY - 2005/9/1

Y1 - 2005/9/1

N2 - Aripiprazole possesses a complex pharmacology with both partial agonist and full antagonist effects. The purpose of this article is to critically review, in the light of its unique receptor pharmacology, the current clinical literature on the use of aripiprazole in the treatment of schizophrenia and mood disorders. There is evidence that aripiprazole is an effective and well tolerated antipsychotic in treating schizophrenia. Now, more recent evidence suggests that aripiprazole may have a role in the treatment of mood disorders. The efficacy side-effect profile of aripiprazole is reviewed herein.

AB - Aripiprazole possesses a complex pharmacology with both partial agonist and full antagonist effects. The purpose of this article is to critically review, in the light of its unique receptor pharmacology, the current clinical literature on the use of aripiprazole in the treatment of schizophrenia and mood disorders. There is evidence that aripiprazole is an effective and well tolerated antipsychotic in treating schizophrenia. Now, more recent evidence suggests that aripiprazole may have a role in the treatment of mood disorders. The efficacy side-effect profile of aripiprazole is reviewed herein.

KW - Aripiprazole

KW - Mood disorders

KW - Schizophrenia

UR - http://www.scopus.com/inward/record.url?scp=26844478735&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=26844478735&partnerID=8YFLogxK

U2 - 10.1586/14750708.2.5.699

DO - 10.1586/14750708.2.5.699

M3 - Review article

VL - 2

SP - 699

EP - 707

JO - Therapy

JF - Therapy

SN - 2044-9038

IS - 5

ER -